|
Coyle M, Brogly S, Ahmed MS, Patrick SW, Jones HE.
"Neonatal Abstinence Syndrome." Nature reviews. Disease primers, vol. 4, no. 47, 2019, pp. 1-17.
|
|
Hardy JR, Pimenta JM, Pokras S, Sehdev H, St. Laurent S, Black L, Coyle MG.
"Risk of hospitalization for common neonatal morbidities in preterm and term infants: Assessing the impact of major congenital anomalies." journal of perinatol, vol. 39, no. 12, 2019, pp. 1602-1610.
|
|
Kaltenbach K, O'Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, Martin PR, Stine S, Jones HE.
"Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes." Drug and Alcohol Dependence, vol. 185, 2018, pp. 40-49.
|
|
Bier, J B, Finger, A S, Bier, B A, Johnson, T A, Coyle, M G.
"Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine." J Perinatol, vol. 35, no. 8, 2015, pp. 656-659.
|
|
Lertsburapa, Terakeith, Vargas, Diana, Lambert-Messerlian, Geralyn, Tantravahi, Umadevi, Gündoğan, Füsun, DeLaMonte, Suzanne, Coyle, Mara G., De Paepe, Monique E.
"Lethal Hypoplasia and Developmental Anomalies of the Lungs in a Newborn with Intrauterine Adrenal Hemorrhage and Cerebral Infarcts: A Proposed Pulmonary Disruption Sequence." Pediatric and Developmental Pathology, vol. 17, no. 5, 2014, pp. 374-381.
|
|
Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G.
"Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure." New England Journal of Medicine, vol. Dec 9, no. 363, 2010, pp. 2320-31.
|
|
Coyle MG, Ferguson A, Lagasse L, Liu J, Lester B.
"Neurobehavioral effects of treatment for opiate withdrawal." Archives of Disease in Childhood - Fetal and Neonatal Edition, vol. 90, no. 1, 2005, pp. F73-4.
|
